Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Xeris Biopharma Holdings, Inc. XERS |
The Vanguard Group | 7,086,345 5.130% |
7,086,345 (New Position) |
Filing History |
| 2024-02-13 4:34 pm Sale |
2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 5,937,000 4.300% |
-5,258,189 (-46.97%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
BLACKROCK INC BLK |
10,011,391 7.200% |
10,011,391 (New Position) |
Filing History |
| 2023-02-14 12:15 pm Sale |
2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
CAXTON CORP | 5,973,324 4.400% |
-1,856,358 (-23.71%) |
Filing History |
| 2023-02-13 10:57 am Purchase |
2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 11,195,189 8.200% |
4,704,090 (+72.47%) |
Filing History |
| 2023-02-10 09:04 am Purchase |
2022-12-31 | 13G | Farmers & Merchants Bancorp, Inc. FMAO |
BLACKROCK INC BLK |
8,576,213 6.300% |
8,576,213 (New Position) |
Filing History |
| 2022-02-11 4:20 pm Purchase |
2021-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 5,882,353 4.500% |
5,882,353 (New Position) |
Filing History |
| 2022-01-13 6:13 pm Purchase |
2022-01-07 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 6,491,099 5.200% |
6,491,099 (New Position) |
Filing History |
| 2022-01-05 12:38 pm Purchase |
2021-10-05 | 13G | Xeris Biopharma Holdings, Inc. XERS |
CAXTON CORP | 7,829,682 5.700% |
7,829,682 (New Position) |
Filing History |